CIK 0001034842 · Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943248524
- Phone
- 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-17 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award | +19,497 | 51,813 | ||
| 2026-02-17 | RODRIGUEZ RAUL R CEO, President | Grant or award | +53,915 | 282,017 | ||
| 2026-02-17 | Santos David A EVP, Chief Commercial Officer | Grant or award | +19,430 | 62,870 | ||
| 2026-02-17 | Rojkjaer Lisa EVP, Chief Medical Officer | Grant or award | +18,894 | 34,853 | ||
| 2026-02-17 | Schorno Dean L EVP & Chief Financial Officer | Grant or award | +20,636 | 76,337 | ||
| 2026-02-10 | Santos David A EVP, Chief Commercial Officer | Shares withheld for taxes | −3,546 | $34.62 | $123K | 43,440 |
| 2026-02-10 | Schorno Dean L EVP & Chief Financial Officer | Shares withheld for taxes | −3,546 | $34.62 | $123K | 55,701 |
| 2026-02-10 | Rojkjaer Lisa EVP, Chief Medical Officer | Shares withheld for taxes | −3,758 | $34.62 | $130K | 15,959 |
| 2026-02-10 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Shares withheld for taxes | −3,546 | $34.62 | $123K | 32,316 |
| 2026-02-10 | RODRIGUEZ RAUL R CEO, President | Shares withheld for taxes | −7,607 | $34.62 | $263K | 228,102 |
| 2026-02-02 | Santos David A EVP, Chief Commercial Officer | Shares withheld for taxes | −5,718 | $36.01 | $206K | 46,986 |
| 2026-02-02 | Schorno Dean L EVP & Chief Financial Officer | Shares withheld for taxes | −5,488 | $36.01 | $198K | 59,247 |
| 2026-02-02 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Shares withheld for taxes | −3,968 | $36.01 | $143K | 35,862 |
| 2026-02-02 | RODRIGUEZ RAUL R CEO, President | Shares withheld for taxes | −14,110 | $36.01 | $508K | 235,709 |
| 2026-02-01 | MILLER MICHAEL PATRICK Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2026-01-26 | RODRIGUEZ RAUL R CEO, President | Option exercise | +40,000 | $27.40 | $1.1M | 280,454 |
| 2026-01-26 | RODRIGUEZ RAUL R CEO, President | Shares withheld for taxes | −35,211 | $37.00 | $1.3M | 245,243 |
| 2026-01-26 | RODRIGUEZ RAUL R CEO, President | Option exercise | +40,000 | $27.40 | $1.1M | 285,243 |
| 2026-01-26 | RODRIGUEZ RAUL R CEO, President | Shares withheld for taxes | −35,424 | $37.00 | $1.3M | 249,819 |
| 2026-01-26 | RODRIGUEZ RAUL R CEO, President | Option exercise · Employee Stock Option (right to buy) | −40,000 | 0 |
Page 3 of 9 · 176 trades